Japan Tissue Engineering Co., Ltd.
Status: Publicly traded
Direct answer
Japan Tissue Engineering Co., Ltd. is publicly traded on JPX under the ticker 7774.T.
Japan Tissue Engineering Co., Ltd. operates within the regenerative medicine sector in Japan. The company's activities are organized into three core divisions: Regenerative Medicine Product, Regenerative Medicine Outsourcing, and Research and Development Support. It manufactures and delivers autologous cultured tissues, such as epidermis, cartilage, corneal epithelium, and oral mucosal epithelium, to medical...
Can you invest in Japan Tissue Engineering Co., Ltd.?
Yes. Japan Tissue Engineering Co., Ltd. trades publicly on JPX as 7774.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Japan Tissue Engineering Co., Ltd.
Detailed equity research is provided by MarketSnap.